ArticleReproductive sciences (Thousand Oaks, Calif.)2025
Effect of THBS1 and P21 Gene Polymorphisms and Their Interaction On Risk of Pre-eclampsia.
Article in Reproductive sciences (Thousand Oaks, Calif.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This study aimed to evaluate the association of THBS1 (Thrombospondin 1) and P21 gene polymorphisms and their interaction with the risk of PE. A case-control study was conducted, involving 175 pregnant women with PE and 350 normotensive pregnant women recruited from two tertiary hospitals. Genotyping of 13 single-nucleotide polymorphisms in the THBS1 and P21 genes was performed using the MassArray platform. Univariate and multivariate logistic regression analyses were performed to evaluate the association between THBS1 and P21 gene polymorphisms and risk of PE. Classification and regression tree (CART) analysis was used to identify potential gene-gene interactions, and logistic regression was applied to assess their impact on PE risk. After adjusting for confounding factors, the THBS1 rs2169830 polymorphism was significantly associated with decreased susceptibility to PE (additive model: aOR = 0.12, p = 0.003), while the P21 rs762624 polymorphism was significantly associated with an increased risk of PE (additive model: aOR = 2.24, p = 0.002). CART and logistic regression analyses identified a significant effect of interaction between polymorphisms in rs762624, rs2292305, and rs1478604 on the susceptibility of PE, with individuals carrying the rs762624CC-rs2292305AA/GG-rs1478604TT/CC genotype combination having the highest risk of PE (aOR = 4.533, p < 0.001). Our findings highlight the importance of THBS1 rs2169830 and P21 rs762624 polymorphisms, along with their interaction, in influencing PE risk. The present study provides a foundation for a more profound understanding of the mechanisms underlying PE.
Indexed as
Identifiers
40524100What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.